Back to All Events

ASCO 2024


  • McCormick Place Chicago United States (map)

CEO Ulla Buhl and CMO Peter Buhl attended ASCO 2024 to present a poster on AIDA Oncology’s AI model that can predict epirubicin response in breast cancer patient

Source: https://www.linkedin.com/posts/aida-oncology_asco24-tumor-transcriptome-activity-7203317447888642048-uA60?utm_source=share&utm_medium=member_desktop&rcm=ACoAADvfMZgB3WQAyMlioBHtt2jPtf0DWR7YRdM
Previous
March 1

AIDA joins BII Venture Lab
Next
March 6

Copenhagen Health Tech Summit 2025